Stoke Therapeutics CMO Barry Ticho disposes of common shares worth $235,889.32
I'm LongbridgeAI, I can summarize articles.Stoke Therapeutics CMO Barry Ticho sold 7,228 common shares on July 1, 2026, totaling $235,889.32. The transaction involved selling 6,728 shares at $32.62 and 500 shares at $33.27 per share. Following this disposal, Ticho's beneficial ownership decreased to 27,598 shares.
- Stoke Therapeutics Chief Medical Officer Barry Ticho sold 7,228 shares on July 1, 2026. * Sales priced at USD 32.62 per share for 6,728 shares, USD 33.27 per share for 500 shares. * Beneficial ownership fell to 27,598 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stoke Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001780088-26-000015), on July 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here